Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-XL expression

Auris Nasus Larynx

Volumn 30, Issue SUPPL., 2003, Pages 79-84

  Otani, Yoshihiro ^a   Tsutsumi, Kouichiro ^a   Kuwahara, Daisuke ^a   Oyake, Daisuke ^a   Ohta, Tomohiko ^a   Nishikawa, Hiroyuki ^a   Koizuka, Izumi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bcl XL; Fas; Head and neck squamous cell carcinoma

Indexed keywords

DACTINOMYCIN; FAS ANTIBODY; OLIGONUCLEOTIDE; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DATA ANALYSIS; DRUG SENSITIVITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; SENSITIZATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; WESTERN BLOTTING;

EID: 0037441403     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0385-8146(02)00128-1     Document Type: Article

References (31)

1. Walker N.I., Harmon B.V., Gobe G.C. Patterns of cell death. Methods Achiev. Exp. Pathol. 13:1988;18-54.
2. O'Connell J., O'Sullivan G.C., Collins J.K. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1996;1075-1082.
3. Michael J.M., Lavin M.F., Watters D.J. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:1991;3600-3605.
4. Kojima H., Endo K., Moriyama H., Tanaka Y., Alnemri E.S., et al. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J. Biol. Chem. 273:1998;16647-16650.
5. Suda T., Takahashi T., Golstein P. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
6. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
7. Ulrike V.R., Jorn S., Walter K., Michael G., Peter H.K., et al. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res. 58:1998;526-534.
8. Selma U., Simone S., Gunter R., Alexandra S., Wolfgang T., et al. Heterogeneous susceptibility to CD95-induced apoptosis in melanoma cells correlates with Bcl-2 and Bcl-x expression and is sensitive to modulation by interferon-γ Int. J. Cancer. 82:1999;727-736.
9. Srinivasan A., Li F., Wong A., Kodandapani L., Smidt R.J., et al. Bcl-XL functions downstream of caspase-8 to inhibit Fas-and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 273:1998;4523-4529.
10. Armstrong R.C., Aga T., Xiang J., Gaur S., Krebs J.F., et al. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:1996;16850-16855.
11. Chinnaiyan A.M., Orth K., O'Rourke K., Duan H., Poirier G.G., et al. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-XL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271:1996;4573-4576.
12. Lee R.K., Spielman J., Podack E.R. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int. Immunol. 8:1996;991-1000.
13. Mandal M., Maggirwar S.B., Sharma N., Kaufmann S.H., Sun S.C., et al. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly (ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J. Biol. Chem. 271:1996;30354-30359.
14. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:1997;3759-3764.
15. Kuwahara D., Tsutsumi K., Kobayashi T., Hasunuma T., Nishioka K. Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells. Cancer Lett. 148:2000;65-71.
16. L expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene. 18:1999;4495-4504.
17. L is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. Int. J. Cancer. 99:2002;29-34.
18. Leithaeuser F., Dhein J., Mechtersheimer G., Koretz K., Bruederlein S., et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:1993;415-429.
19. Owen-Schaub L.B., Radinsky R., Kruzel E., Berry K., Yonehara S., et al. Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1994;1580-1586.
20. Cohen G.M. Caspase: the executioners of apoptosis. Biochem. J. 326:1997;1-16.
21. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
22. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
23. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:1998;2926-2930.
24. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
25. Wu D., Wallen H.D., Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275:1997;1126-1129.
26. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
27. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
28. Li P., Nijhawan D., Bonavidjo I., Srinivasula S.M., Ahmad M., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
29. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
30. L inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115-3120.
31. Adachi S., Cross A.R., Babior B.M., Gottlieb R.A. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J. Biol. Chem. 272:1997;21878-21882.